These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 18757096
1. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia. Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O. Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096 [Abstract] [Full Text] [Related]
2. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832 [Abstract] [Full Text] [Related]
3. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Galm O, Wilop S, Lüders C, Jost E, Gehbauer G, Herman JG, Osieka R. Ann Hematol; 2005 Dec 15; 84 Suppl 1():39-46. PubMed ID: 16231140 [Abstract] [Full Text] [Related]
4. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S, Said JW, Popoviciu LM, Jones PA, Miyakawa I, Koeffler HP. Mol Cancer Res; 2005 May 15; 3(5):261-9. PubMed ID: 15886297 [Abstract] [Full Text] [Related]
5. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman JG, Osieka R, Galm O. Br J Haematol; 2008 Sep 15; 142(5):745-53. PubMed ID: 18537968 [Abstract] [Full Text] [Related]
6. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. Mol Cancer Res; 2005 Oct 15; 3(10):585-96. PubMed ID: 16254192 [Abstract] [Full Text] [Related]
7. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP. Genes Chromosomes Cancer; 2003 Feb 15; 36(2):167-74. PubMed ID: 12508245 [Abstract] [Full Text] [Related]
8. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia. Yao DM, Qian J, Lin J, Wang YL, Chen Q, Qian Z, Li Y, Wang CZ, Yang J. Leuk Res; 2011 Jul 15; 35(7):957-60. PubMed ID: 21106240 [Abstract] [Full Text] [Related]
9. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells. Liu YN, Kang BB, Chen JH. Oncogene; 2004 Jan 08; 23(1):278-88. PubMed ID: 14712233 [Abstract] [Full Text] [Related]
10. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features. Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW. Leuk Res; 2011 Feb 08; 35(2):200-7. PubMed ID: 20970189 [Abstract] [Full Text] [Related]
11. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L. Oncogene; 2011 Aug 04; 30(31):3416-28. PubMed ID: 21399664 [Abstract] [Full Text] [Related]
12. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia]. Zhao JM, Wang HW, Xu ZF, Zhu L, Bai B, Ge XY. Zhonghua Xue Ye Xue Za Zhi; 2005 May 04; 26(5):299-302. PubMed ID: 15949295 [Abstract] [Full Text] [Related]
13. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Chim CS, Wong AS, Kwong YL. Ann Hematol; 2003 Dec 04; 82(12):738-42. PubMed ID: 14513284 [Abstract] [Full Text] [Related]
14. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Shimamoto T, Ohyashiki JH, Ohyashiki K. Leuk Res; 2005 Jun 04; 29(6):653-9. PubMed ID: 15863205 [Abstract] [Full Text] [Related]
15. Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia. Ogawa M, Sakashita K, Zhao XY, Hayakawa A, Kubota T, Koike K. Leuk Res; 2007 May 04; 31(5):611-21. PubMed ID: 17074388 [Abstract] [Full Text] [Related]
16. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation. Nanri T, Uike N, Kawakita T, Iwanaga E, Mitsuya H, Asou N. Genes Chromosomes Cancer; 2010 Mar 04; 49(3):237-41. PubMed ID: 19953636 [Abstract] [Full Text] [Related]
17. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. Nat Genet; 2001 Mar 04; 27(3):263-70. PubMed ID: 11242107 [Abstract] [Full Text] [Related]
18. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. Cancer Res; 2007 May 15; 67(10):4657-64. PubMed ID: 17510391 [Abstract] [Full Text] [Related]
19. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Cancer Res; 2005 Feb 01; 65(3):861-7. PubMed ID: 15705884 [Abstract] [Full Text] [Related]